Almac Group Launches Almac Adapt™ – a New Patient-Centric Supply Solution

Innovative Just in Time Manufacturing (JTM) enables sponsors full late stage customisation of their clinical trial materials

Craigavon, N.I., 13 June 2019 – Almac Clinical Services, part of the Almac Group, has today announced the launch of Almac Adapt™ – an innovative Just in Time Manufacturing (JTM) solution.  This latest offering puts patients first and provides sponsors with a unique, adaptive supply strategy to ultimately meet the expanding challenges of clinical trials.
Read More

Almac Group Reports Further Growth During Period of Significant Global Expansion

2017-18 figures record turnover increased by £17 million with 8% growth in global workforce

Craigavon, N.I., 03 Jun 2019 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, has reported a £17 million rise in turnover from £531 million to £548 million for 2017-18.  Pre-tax profits were recorded at £27 million whilst average employee figures increased by 8% from 4,407 to 4,798 for the same period. The figures were recorded in Almac’s annual report with its results for the year ending 30 September 2018.
Read More

Congratulations, Almac Group, on being named in top 5 most profitable Northern Ireland controlled private businesses by BDONI.

Click HERE to read more.